EGFR and triple-negative breast carcinoma: Of note, in triple-negative breast cancer (TNBC) cells, it was shown that epidermal growth factor (EGF) signaling activates the first step of glycolysis, and F-1,6-BP directly binds to epidermal growth factor receptor (EGFR), enhancing its activity [70].